This TNFRSF14 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 269-302 amino acids from the C-terminal region of human TNFRSF14.
Alternative Names:
TR2, ATAR, HVEA, HVEM, CD270, LIGHTR
Receptor for BTLA. Receptor for TNFSF14/LIGHT and homotrimeric TNFSF1/lymphotoxin-alpha. Involved in lymphocyte activation. Plays an important role in HSV pathogenesis because it enhanced the entry of several wild-type HSV strains of both serotypes into CHO cells, and mediated HSV entry into activated human T-cells.